OXEIA

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Oct 2021 filing date already counts against anyone who files later.

Record

Serial number

97097829

Mark type

Design + words

Filed

28 Oct 2021

Published for opposition

23 Sept 2025

Attorney of record

Karen Won

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating neurotrauma and neuro-metabolic dysfunction; pharmaceutical preparations for treating concussions, brain injuries and dysfunctions, neurodegeneration, and neurologic diseases, conditions, and disorders; therapeutic preparations, namely, endogenous hormones and synthetic human ghrelin for stabilizing brain metabolism and energy.
• Class 042 — Scientific and technological services: Pharmaceutical research and development; providing medical and scientific research information in the fields of concussions, brain injury, neurodegeneration, and neurology

Owner

• Oxeia Biopharmaceuticals, Inc., Boston, MA, US
• Oxeia Biopharmaceuticals, Inc., Boston, MA, US

Prosecution history

• 18 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 23 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 23 Sept 2025 — PUBLISHED FOR OPPOSITION
• 17 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 26 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 26 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 25 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 25 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 12 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 12 Jun 2025 — NON-FINAL ACTION E-MAILED
• 12 Jun 2025 — NON-FINAL ACTION WRITTEN
• 12 Dec 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 09 Feb 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 09 Feb 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 12 Aug 2023 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED